| Product Code: ETC6748503 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Neurological Biomarkers Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Neurological Biomarkers Market Revenues & Volume, 2021 & 2031F |
3.3 China Neurological Biomarkers Market - Industry Life Cycle |
3.4 China Neurological Biomarkers Market - Porter's Five Forces |
3.5 China Neurological Biomarkers Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 China Neurological Biomarkers Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 China Neurological Biomarkers Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 China Neurological Biomarkers Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in China |
4.2.2 Growing awareness about early diagnosis and treatment of neurological conditions |
4.2.3 Technological advancements in biomarker research |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for biomarker approval |
4.3.2 Limited reimbursement policies for neurological biomarker testing in China |
5 China Neurological Biomarkers Market Trends |
6 China Neurological Biomarkers Market, By Types |
6.1 China Neurological Biomarkers Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 China Neurological Biomarkers Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 China Neurological Biomarkers Market Revenues & Volume, By Genomic Biomarkers, 2021- 2031F |
6.1.4 China Neurological Biomarkers Market Revenues & Volume, By Proteomic Biomarkers, 2021- 2031F |
6.1.5 China Neurological Biomarkers Market Revenues & Volume, By Metabolomic Biomarkers, 2021- 2031F |
6.1.6 China Neurological Biomarkers Market Revenues & Volume, By Imaging Biomarkers, 2021- 2031F |
6.1.7 China Neurological Biomarkers Market Revenues & Volume, By Others, 2021- 2031F |
6.2 China Neurological Biomarkers Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 China Neurological Biomarkers Market Revenues & Volume, By Alzheimer's Disease, 2021- 2031F |
6.2.3 China Neurological Biomarkers Market Revenues & Volume, By Parkinson's Disease, 2021- 2031F |
6.2.4 China Neurological Biomarkers Market Revenues & Volume, By Multiple Sclerosis, 2021- 2031F |
6.2.5 China Neurological Biomarkers Market Revenues & Volume, By Autism Spectrum Disorders, 2021- 2031F |
6.2.6 China Neurological Biomarkers Market Revenues & Volume, By Others, 2021- 2031F |
6.3 China Neurological Biomarkers Market, By End Use |
6.3.1 Overview and Analysis |
6.3.2 China Neurological Biomarkers Market Revenues & Volume, By Hospital Laboratories, 2021- 2031F |
6.3.3 China Neurological Biomarkers Market Revenues & Volume, By Clinical Diagnostic Centers, 2021- 2031F |
6.3.4 China Neurological Biomarkers Market Revenues & Volume, By Research Organizations, 2021- 2031F |
6.3.5 China Neurological Biomarkers Market Revenues & Volume, By Others, 2021- 2031F |
7 China Neurological Biomarkers Market Import-Export Trade Statistics |
7.1 China Neurological Biomarkers Market Export to Major Countries |
7.2 China Neurological Biomarkers Market Imports from Major Countries |
8 China Neurological Biomarkers Market Key Performance Indicators |
8.1 Adoption rate of neurological biomarker testing in clinical practice |
8.2 Number of research studies incorporating neurological biomarkers in China |
8.3 Investment in RD for developing new neurological biomarkers |
9 China Neurological Biomarkers Market - Opportunity Assessment |
9.1 China Neurological Biomarkers Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 China Neurological Biomarkers Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 China Neurological Biomarkers Market Opportunity Assessment, By End Use, 2021 & 2031F |
10 China Neurological Biomarkers Market - Competitive Landscape |
10.1 China Neurological Biomarkers Market Revenue Share, By Companies, 2024 |
10.2 China Neurological Biomarkers Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here